Cargando…

Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice

Summary: PTH stimulates bone formation in Fgfr3 knockout mice through promotion of proliferation and differentiation in osteoblasts. Introduction: Previous studies showed that endogenous fibroblast growth factor 2 (FGF-2) is required for parathyroid hormone (PTH)-stimulated bone anabolic effects, ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yangli, Yi, Lingxian, Weng, Tujun, Huang, Junlan, Luo, Fengtao, Jiang, Wanling, Xian, Cory J, Du, Xiaolan, Chen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971737/
https://www.ncbi.nlm.nih.gov/pubmed/27489502
http://dx.doi.org/10.7150/ijbs.14077
_version_ 1782446161134616576
author Xie, Yangli
Yi, Lingxian
Weng, Tujun
Huang, Junlan
Luo, Fengtao
Jiang, Wanling
Xian, Cory J
Du, Xiaolan
Chen, Lin
author_facet Xie, Yangli
Yi, Lingxian
Weng, Tujun
Huang, Junlan
Luo, Fengtao
Jiang, Wanling
Xian, Cory J
Du, Xiaolan
Chen, Lin
author_sort Xie, Yangli
collection PubMed
description Summary: PTH stimulates bone formation in Fgfr3 knockout mice through promotion of proliferation and differentiation in osteoblasts. Introduction: Previous studies showed that endogenous fibroblast growth factor 2 (FGF-2) is required for parathyroid hormone (PTH)-stimulated bone anabolic effects, however, the exact mechanisms by which PTH stimulate bone formation and the function of FGF receptors in mediating these actions are not fully defined. FGF receptor 3 (FGFR3) has been characterized as an important regulator of bone metabolism and is confirmed to cross-talk with PTH/PTHrP signal in cartilage and bone development. Methods: Fgfr3 knockout and wild-type mice at 2-month-old and 4-month-old were intraperitoneally injected with PTH intermittently for 4 weeks and then the skeletal responses to PTH were assessed by dual energy X-ray absorptiometry (DEXA), micro-computed tomography (μCT) and bone histomorphometry. Results: Intermittent PTH treatment improved bone mineral density (BMD) and femoral mechanical properties in both Fgfr3(-/-) and wild-type mice. Histomorphometric analysis showed that bone formation and bone resorption were increased in both genotypes following PTH treatment. PTH treatment increased trabecular bone volume (BV/TV) in WT and Fgfr3-deficient mice. The anabolic response in Fgfr3-deficient and wild-type bone is characterized by an increase of both bone formation and resorption-related genes following PTH treatment. In addition, we found that Fgfr3 null osteoblasts (compared to wild-type controls) maintained normal abilities to response to PTH-stimulated increase of proliferation, differentiation, expression of osteoblastic marker genes (Cbfa1, Osteopontin and Osteocalcin), and phosphorylation of Erk1/2. Conclusions: Bone anabolic effects of PTH were not impaired by the absence of FGFR3, suggesting that the FGFR3 signaling may not be required for osteoanabolic effects of PTH activities.
format Online
Article
Text
id pubmed-4971737
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-49717372016-08-03 Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice Xie, Yangli Yi, Lingxian Weng, Tujun Huang, Junlan Luo, Fengtao Jiang, Wanling Xian, Cory J Du, Xiaolan Chen, Lin Int J Biol Sci Research Paper Summary: PTH stimulates bone formation in Fgfr3 knockout mice through promotion of proliferation and differentiation in osteoblasts. Introduction: Previous studies showed that endogenous fibroblast growth factor 2 (FGF-2) is required for parathyroid hormone (PTH)-stimulated bone anabolic effects, however, the exact mechanisms by which PTH stimulate bone formation and the function of FGF receptors in mediating these actions are not fully defined. FGF receptor 3 (FGFR3) has been characterized as an important regulator of bone metabolism and is confirmed to cross-talk with PTH/PTHrP signal in cartilage and bone development. Methods: Fgfr3 knockout and wild-type mice at 2-month-old and 4-month-old were intraperitoneally injected with PTH intermittently for 4 weeks and then the skeletal responses to PTH were assessed by dual energy X-ray absorptiometry (DEXA), micro-computed tomography (μCT) and bone histomorphometry. Results: Intermittent PTH treatment improved bone mineral density (BMD) and femoral mechanical properties in both Fgfr3(-/-) and wild-type mice. Histomorphometric analysis showed that bone formation and bone resorption were increased in both genotypes following PTH treatment. PTH treatment increased trabecular bone volume (BV/TV) in WT and Fgfr3-deficient mice. The anabolic response in Fgfr3-deficient and wild-type bone is characterized by an increase of both bone formation and resorption-related genes following PTH treatment. In addition, we found that Fgfr3 null osteoblasts (compared to wild-type controls) maintained normal abilities to response to PTH-stimulated increase of proliferation, differentiation, expression of osteoblastic marker genes (Cbfa1, Osteopontin and Osteocalcin), and phosphorylation of Erk1/2. Conclusions: Bone anabolic effects of PTH were not impaired by the absence of FGFR3, suggesting that the FGFR3 signaling may not be required for osteoanabolic effects of PTH activities. Ivyspring International Publisher 2016-07-17 /pmc/articles/PMC4971737/ /pubmed/27489502 http://dx.doi.org/10.7150/ijbs.14077 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions.
spellingShingle Research Paper
Xie, Yangli
Yi, Lingxian
Weng, Tujun
Huang, Junlan
Luo, Fengtao
Jiang, Wanling
Xian, Cory J
Du, Xiaolan
Chen, Lin
Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
title Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
title_full Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
title_fullStr Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
title_full_unstemmed Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
title_short Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
title_sort fibroblast growth factor receptor 3 deficiency does not impair the osteoanabolic action of parathyroid hormone on mice
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971737/
https://www.ncbi.nlm.nih.gov/pubmed/27489502
http://dx.doi.org/10.7150/ijbs.14077
work_keys_str_mv AT xieyangli fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT yilingxian fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT wengtujun fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT huangjunlan fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT luofengtao fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT jiangwanling fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT xiancoryj fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT duxiaolan fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice
AT chenlin fibroblastgrowthfactorreceptor3deficiencydoesnotimpairtheosteoanabolicactionofparathyroidhormoneonmice